OVIDREL
OVIDREL
Approved
DIN Number
02262088
Drug Class
Human
Market Date
Dec 20, 2004
Company
HC
emd serono, a division of emd inc., canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02262088
AIG Number0150432003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
G03GA08 CHORIOGONADOTROPIN ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:18.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CHORIOGONADOTROPIN ALFAActive
Strength: 250 MCG / 0.5 ML
Monograph: CHORIOGONADOTROPIN ALFA